Skip to main content
. 2024 Jan 8;14:13. doi: 10.1038/s41398-023-02686-x

Fig. 5. Rescue effects of metformin.

Fig. 5

A Metformin rescues autophagy defects in olanzapine-treated cells. HepG2 cells were transfected with mRFP-GFP-LC3 vector and incubated with 5 mM metformin (Met) alone or with 5 μM U18666A, 25μM risperidone (RIS), olanzapine (OLA) in the presence or absence of 5 mM metformin for 24 h. Cells were then fixed, labelled with anti LAMP1 Ab (blue) and analysed by confocal microscopy. mRFP-GFP-LC3 positive autophagosomes are showed in yellow. Scale bar = 10 µm. B The total number of mRFP-LC3 vesicles; (C) the percentage of mRFP+ LC3 vesicles colocalizing with LAMP1; D the percentage of mRFP+, GFP- LC3 vesicles, corresponding to autolysosomes; E the percentage of mRFP+, GFP+ LC3 vesicles colocalizing with LAMP1 (white vesicles) were quantified and reported in the graphs (one way ANOVA followed by Sidak’s multiple comparison test; n=45 cells). F Metformin does not rescue LD accumulation due to olanzapine and risperidone in AMPK-silenced cells. G The Oil-Red-O -DAPI assay reported in Fig.4 panels D, E, F was performed in AMPK-silenced HepG2 cells. H, I Metformin does not rescue autophagy defects in AMPK-silenced olanzapine-treated cells. The mRFP-GFP-LC3 autophagy assay reported in panels A, B, E was performed and analysed in AMPK-silenced HepG2 cells.